In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Meristem Therapeutics SA

www.meristem-therapeutics.com

Latest From Meristem Therapeutics SA

Deals Shaping The Medical Industry, January 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Pharmaceuticals, and Medical Devices – and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

DEALS ROUND-UP: M&A and partnering 1-28 December

As companies flurried to clinch deals by the end of the year, a number of significant agreements were signed or completed last December.

Metabolic Disorders Infectious Diseases

Protein Production Start-Ups

Should a disruptive protein production technology emerge, the current interest in developing large-molecule therapeutics assures there would be many takers.
BioPharmaceutical Innovation

Can France Stay in the Game?

The French government's efforts to encourage biotechnology have been modest and somewhat piecemeal. Yet two years ago, France's industry was nevertheless ranked second in Europe. Since then, the explosion of biotech companies in Germany, along with steady growth in other European markets, make the need for a coherent French strategy more urgent. France needs to take some bolder, more generous measures--particularly to reduce companies' tax burden and attract talent from overseas--without which it risks restricting itself to a small group of companies, many of whom will have to move elsewhere to grow substantially.
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
    • Synthesis Technologies, Production Processes
    • Transgenics
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Meristem Therapeutics SA
  • Senior Management
  • Bertrand Merot, Chmn. & CEO
  • Contact Info
  • Meristem Therapeutics SA
    Phone: (33) 473 986 810
    8 Rue des Freres Lumiere
    Clermont-Ferrand, 63100
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register